Turbovap LV evaporation system (2EA)

The Food and Drug Administration Office of Acquisition and Grant Services seeks two Biotage TurboVap LV solvent evaporation systems for high-throughput sample preparation, with quotations due August 10. The procurement is conducted as a Request for Quotation under FAR Part 12 simplified commercial procedures and carries no set-aside.

Place of performance is Denver, Colorado, specifically the Denver Human and Animal Food Laboratory. The systems must be capable of removing organic solvents from extracted samples using compressed air or nitrogen with vortex gas shearing technology, feature a heated water bath with temperature control and touchscreen interface with programmable methods, and accommodate specific solvents including acetonitrile, ethyl acetate, methanol, formic acid, and water. Electrical supply must be 100–127V or 220–240V at 50/60 Hz with appropriate exhaust ventilation. All equipment must be new.

Deliverables include two TurboVap LV Systems (Product No. 415000), two multi-racks for 48-position tube capacity (10–20mm, Part No. 414964), two mains cords (US/CA, Model C65902SP), shipping, and technical support and user documentation. Award is anticipated as a single firm-fixed price purchase order with delivery required within 60 calendar days of contract award. The anticipated period of performance runs August 31, 2026 through August 30, 2027, with manufacturer's standard commercial warranty of no less than one year from government acceptance. Evaluation uses lowest price technically acceptable, with technical acceptability determined on a pass/fail basis. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing. Questions are due within three business days of solicitation posting. Submission must include technical and price quotations, warranty terms, UEI/SAM.gov confirmation, lead time, and country of origin for all items.